BACKGROUND: 5'-AMP-activated protein kinase (AMPK) inactivates critial ensymes in fatty acid and cholesterol synthesis. We hypothesised that the serum lipid profile may be influenced by genetic variation in the AMPK catalytic alpha2 subunit. METHOD: We examined association of 5 tagging SNPs (tSNPs) in the PRKAA2 gene with serum lipids in 2777 normal Caucasian females (mean age 47.4+/-12.5 years). RESULTS: All tSNPs were associated with total- and LDL-cholesterol, (p<0.001 to 0.034), explaining variances of 0.13-0.59% and 0.11-0.55% respectively. One haplotype (frequency 34.7%) showed lower total- and LDL-cholesterol compared with the most common haplotype (frequency 45.7%) (p< or =0.001), explaining 0.78% of total- and 0.75% of LDL-cholesterol. Another haplotype (frequency 10.5%) was significantly associated with lower HDL-cholesterol (p = 0.005), explaining 0.59% of variance. CONCLUSIONS: PRKAA2 gene variants are significantly associated with serum lipoproteins in a large sample of normal female Caucasians.
BACKGROUND: 5'-AMP-activated protein kinase (AMPK) inactivates critial ensymes in fatty acid and cholesterol synthesis. We hypothesised that the serum lipid profile may be influenced by genetic variation in the AMPK catalytic alpha2 subunit. METHOD: We examined association of 5 tagging SNPs (tSNPs) in the PRKAA2 gene with serum lipids in 2777 normal Caucasian females (mean age 47.4+/-12.5 years). RESULTS: All tSNPs were associated with total- and LDL-cholesterol, (p<0.001 to 0.034), explaining variances of 0.13-0.59% and 0.11-0.55% respectively. One haplotype (frequency 34.7%) showed lower total- and LDL-cholesterol compared with the most common haplotype (frequency 45.7%) (p< or =0.001), explaining 0.78% of total- and 0.75% of LDL-cholesterol. Another haplotype (frequency 10.5%) was significantly associated with lower HDL-cholesterol (p = 0.005), explaining 0.59% of variance. CONCLUSIONS:PRKAA2 gene variants are significantly associated with serum lipoproteins in a large sample of normal female Caucasians.
Authors: Dmitri V Zaykin; Peter H Westfall; S Stanley Young; Maha A Karnoub; Michael J Wagner; Margaret G Ehm Journal: Hum Hered Date: 2002 Impact factor: 0.444
Authors: Daniel O Stram; Christopher A Haiman; Joel N Hirschhorn; David Altshuler; Laurence N Kolonel; Brian E Henderson; Malcolm C Pike Journal: Hum Hered Date: 2003 Impact factor: 0.444
Authors: Yasuhiko Minokoshi; Young-Bum Kim; Odile D Peroni; Lee G D Fryer; Corinna Müller; David Carling; Barbara B Kahn Journal: Nature Date: 2002-01-17 Impact factor: 49.962
Authors: Benoit Viollet; Fabrizio Andreelli; Sebastian B Jørgensen; Christophe Perrin; Alain Geloen; Daisy Flamez; James Mu; Claudia Lenzner; Olivier Baud; Myriam Bennoun; Emmanuel Gomas; Gaël Nicolas; Jørgen F P Wojtaszewski; Axel Kahn; David Carling; Frans C Schuit; Morris J Birnbaum; Erik A Richter; Rémy Burcelin; Sophie Vaulont Journal: J Clin Invest Date: 2003-01 Impact factor: 14.808
Authors: Rita P S Middelberg; Tim D Spector; Ramasamyiyer Swaminathan; Harold Snieder Journal: Arterioscler Thromb Vasc Biol Date: 2002-07-01 Impact factor: 8.311
Authors: Liang-Hui Chu; Chaitanya G Vijay; Brian H Annex; Joel S Bader; Aleksander S Popel Journal: Physiol Genomics Date: 2015-06-09 Impact factor: 3.107
Authors: P Weyrich; F Machicao; H Staiger; P Simon; C Thamer; J Machann; F Schick; A Guirguis; A Fritsche; N Stefan; H-U Häring Journal: Diabetologia Date: 2007-08-14 Impact factor: 10.122
Authors: Grzegorz Palczewski; M Airanthi K Widjaja-Adhi; Jaume Amengual; Marcin Golczak; Johannes von Lintig Journal: J Lipid Res Date: 2016-07-07 Impact factor: 5.922